nVerses Capital »

Denali Therapeutics shares owned by nVerses Capital

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by nVerses Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $288k 9.9k 29.13